52 related articles for article (PubMed ID: 22432682)
1. Pyrazolo[4,3-c][1,2]benzothiazines 5,5-dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors.
Sabatini S; Gosetto F; Serritella S; Manfroni G; Tabarrini O; Iraci N; Brincat JP; Carosati E; Villarini M; Kaatz GW; Cecchetti V
J Med Chem; 2012 Apr; 55(7):3568-72. PubMed ID: 22432682
[TBL] [Abstract][Full Text] [Related]
2. From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search.
Cedraro N; Cannalire R; Astolfi A; Mangiaterra G; Felicetti T; Vaiasicca S; Cernicchi G; Massari S; Manfroni G; Tabarrini O; Cecchetti V; Barreca ML; Biavasco F; Sabatini S
ChemMedChem; 2021 Oct; 16(19):3044-3059. PubMed ID: 34032014
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the Molecular Recognition Mechanism of Multidrug Resistance
Palazzotti D; Bissaro M; Bolcato G; Astolfi A; Felicetti T; Sabatini S; Sturlese M; Cecchetti V; Barreca ML; Moro S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430864
[TBL] [Abstract][Full Text] [Related]
4. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
Smith EC; Kaatz GW; Seo SM; Wareham N; Williamson EM; Gibbons S
Antimicrob Agents Chemother; 2007 Dec; 51(12):4480-3. PubMed ID: 17664318
[TBL] [Abstract][Full Text] [Related]
5. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor.
Stermitz FR; Lorenz P; Tawara JN; Zenewicz LA; Lewis K
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1433-7. PubMed ID: 10677479
[TBL] [Abstract][Full Text] [Related]
6. Proton-coupled transport mechanism of the efflux pump NorA.
Li J; Li Y; Koide A; Kuang H; Torres VJ; Koide S; Wang DN; Traaseth NJ
Nat Commun; 2024 May; 15(1):4494. PubMed ID: 38802368
[TBL] [Abstract][Full Text] [Related]
7. Endophytes: a uniquely tailored source of potential antibiotic adjuvants.
Moussa AY
Arch Microbiol; 2024 Apr; 206(5):207. PubMed ID: 38581477
[TBL] [Abstract][Full Text] [Related]
8. Bibliometric insights into the most influential papers on antibiotic adjuvants: a comprehensive analysis.
Sun K; Xu P; Zhang Y; Yu P; Ju Y
Front Pharmacol; 2023; 14():1276018. PubMed ID: 38027012
[No Abstract] [Full Text] [Related]
9. Inhibition of
Rampacci E; Felicetti T; Cernicchi G; Stefanetti V; Sabatini S; Passamonti F
Antibiotics (Basel); 2023 Apr; 12(5):. PubMed ID: 37237709
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance.
Dhanda G; Acharya Y; Haldar J
ACS Omega; 2023 Mar; 8(12):10757-10783. PubMed ID: 37008128
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial screening to molecular docking of newly synthesized ferrocenyl-substituted pyrazole.
Sharma S; Tuli HS; Varol M; Agarwal P; Rani A; Abbas Z; Kumar M
Int J Health Sci (Qassim); 2022; 16(4):3-12. PubMed ID: 35949692
[TBL] [Abstract][Full Text] [Related]
12. Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.
Monteiro KLC; Silva ON; Dos Santos Nascimento IJ; Mendonça Júnior FJB; Aquino PGV; da Silva-Júnior EF; de Aquino TM
Curr Top Med Chem; 2022; 22(24):1983-2028. PubMed ID: 35319372
[TBL] [Abstract][Full Text] [Related]
13. Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition.
Dashtbani-Roozbehani A; Brown MH
Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943714
[TBL] [Abstract][Full Text] [Related]
14. Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant
Thamilselvan G; Sarveswari HB; Vasudevan S; Stanley A; Shanmugam K; Vairaprakash P; Solomon AP
Front Cell Infect Microbiol; 2021; 11():700198. PubMed ID: 34485178
[TBL] [Abstract][Full Text] [Related]
15. Functional and Structural Roles of the Major Facilitator Superfamily Bacterial Multidrug Efflux Pumps.
Kumar S; Lekshmi M; Parvathi A; Ojha M; Wenzel N; Varela MF
Microorganisms; 2020 Feb; 8(2):. PubMed ID: 32079127
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Antimicrobial Activity of 1,2-Benzothiazine Derivatives.
Patel C; Bassin JP; Scott M; Flye J; Hunter AP; Martin L; Goyal M
Molecules; 2016 Jun; 21(7):. PubMed ID: 27376253
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus.
Handzlik J; Matys A; Kieć-Kononowicz K
Antibiotics (Basel); 2013 Feb; 2(1):28-45. PubMed ID: 27029290
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.
Kumar S; Mukherjee MM; Varela MF
Int J Bacteriol; 2013; 2013():. PubMed ID: 25750934
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.
Gill EE; Franco OL; Hancock RE
Chem Biol Drug Des; 2015 Jan; 85(1):56-78. PubMed ID: 25393203
[TBL] [Abstract][Full Text] [Related]
20. The intrinsic resistome of bacterial pathogens.
Olivares J; Bernardini A; Garcia-Leon G; Corona F; B Sanchez M; Martinez JL
Front Microbiol; 2013; 4():103. PubMed ID: 23641241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
